Bill > SB250

This bill, known as the "Right to Try for Individualized Treatments Act," establishes a framework for patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments based on their unique genetic profile. An eligible patient must have a recommendation from their physician, have exhausted all FDA-approved treatment options, and provide written informed consent that clearly explains potential risks and outcomes. The bill allows manufacturers operating in eligible facilities to make these personalized treatments available, though they are not required to do so. Manufacturers can provide the treatment without compensation or require the patient to cover associated costs. The bill protects healthcare providers from disciplinary action for recommending these treatments and ensures that no state official can block a patient's access to such treatments. Importantly, the bill does not create a private cause of action against manufacturers or healthcare providers if the patient experiences harm, provided they act in good faith and with reasonable care. The legislation also addresses patient privacy by requiring consent and disclosure if a patient's biospecimen is used for purposes beyond their individual treatment, including potential commercial applications. Ultimately, the bill aims to give patients with serious illnesses more options for potentially life-saving personalized medical treatments.

Health and Social Services

Public Health and Welfare (Senate)

https://kslegislature.gov/li/b2025_26/measures/sb250/